Frontiers in Neurology (Jan 2022)
Reducing the Risk of Cognitive Decline and Dementia: WHO Recommendations
- Neerja Chowdhary,
- Corrado Barbui,
- Kaarin J. Anstey,
- Miia Kivipelto,
- Miia Kivipelto,
- Miia Kivipelto,
- Miia Kivipelto,
- Mariagnese Barbera,
- Mariagnese Barbera,
- Ruth Peters,
- Ruth Peters,
- Lidan Zheng,
- Lidan Zheng,
- Jenni Kulmala,
- Jenni Kulmala,
- Jenni Kulmala,
- Ruth Stephen,
- Cleusa P. Ferri,
- Yves Joanette,
- Huali Wang,
- Huali Wang,
- Adelina Comas-Herrera,
- Charles Alessi,
- Kusumadewi Suharya (Dy),
- Kibachio J. Mwangi,
- Ronald C. Petersen,
- Ayesha A. Motala,
- Shanthi Mendis,
- Dorairaj Prabhakaran,
- Ameenah Bibi Mia Sorefan,
- Amit Dias,
- Riadh Gouider,
- Riadh Gouider,
- Suzana Shahar,
- Kimberly Ashby-Mitchell,
- Martin Prince,
- Tarun Dua
Affiliations
- Neerja Chowdhary
- Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland
- Corrado Barbui
- Department of Neuroscience, Biomedicine and Movement Sciences, WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, University of Verona, Verona, Italy
- Kaarin J. Anstey
- University of New South Wales, Sydney, NSW, Australia
- Miia Kivipelto
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden
- Miia Kivipelto
- The Ageing Epidemiology Research Unit, Imperial College London, School of Public Health, London, United Kingdom
- Miia Kivipelto
- Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
- Miia Kivipelto
- Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden
- Mariagnese Barbera
- The Ageing Epidemiology Research Unit, Imperial College London, School of Public Health, London, United Kingdom
- Mariagnese Barbera
- Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland
- Ruth Peters
- University of New South Wales, Sydney, NSW, Australia
- Ruth Peters
- Neuroscience Research Australia, Sydney, NSW, Australia
- Lidan Zheng
- University of New South Wales, Sydney, NSW, Australia
- Lidan Zheng
- Neuroscience Research Australia, Sydney, NSW, Australia
- Jenni Kulmala
- Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden
- Jenni Kulmala
- 0Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland
- Jenni Kulmala
- 1Faculty of Social Sciences (Health Sciences) and Gerontology Research Centre (GEREC), Tampere University, Tampere, Finland
- Ruth Stephen
- Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland
- Cleusa P. Ferri
- 2Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil
- Yves Joanette
- 3Canadian Institutes of Health Research, Government of Canada, Ottawa, ON, Canada
- Huali Wang
- 4Dementia Care and Research Center, Peking University Institute of Mental Health, Beijing, China
- Huali Wang
- 5Beijing Dementia Key Laboratory, Beijing, China
- Adelina Comas-Herrera
- 6Department of Health Policy, Care Policy and Evaluation Centre, London School of Economics and Political Science, London, United Kingdom
- Charles Alessi
- 7Public Health England, London, United Kingdom
- Kusumadewi Suharya (Dy)
- 8Alzheimer's Disease International, Jakarta, Indonesia
- Kibachio J. Mwangi
- 9Division of Non-communicable Diseases, Ministry of Health, Nairobi, Kenya
- Ronald C. Petersen
- 0Mayo Clinic, Rochester, MN, United States
- Ayesha A. Motala
- 1University of KwaZulu-Natal, Durban, South Africa
- Shanthi Mendis
- 2The Geneva Learning Foundation, Geneva, Switzerland
- Dorairaj Prabhakaran
- 3Public Health Foundation of India, New Delhi, India
- Ameenah Bibi Mia Sorefan
- 4Alzheimer Association, Quatre Bornes, Mauritius
- Amit Dias
- 5Department of Preventive and Social Medicine, Goa Medical College, Goa, India
- Riadh Gouider
- 6Faculty of Medicine, Clinical Investigation Centre Neurosciences and Mental Health Razi University Hospital, Tunis, Tunisia
- Riadh Gouider
- 7Faculty of Medicine, University Tunis El Manar, Tunis, Tunisia
- Suzana Shahar
- 8Centre for Healthy Aging and Wellness, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
- Kimberly Ashby-Mitchell
- 9The Mona Ageing and Wellness Centre, University of the West Indies, Kingston, Jamaica
- Martin Prince
- 0King's College London, London, United Kingdom
- Tarun Dua
- Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland
- DOI
- https://doi.org/10.3389/fneur.2021.765584
- Journal volume & issue
-
Vol. 12
Abstract
With population ageing worldwide, dementia poses one of the greatest global challenges for health and social care in the 21st century. In 2019, around 55 million people were affected by dementia, with the majority living in low- and middle-income countries. Dementia leads to increased costs for governments, communities, families and individuals. Dementia is overwhelming for the family and caregivers of the person with dementia, who are the cornerstone of care and support systems throughout the world. To assist countries in addressing the global burden of dementia, the World Health Organisation (WHO) developed the Global Action Plan on the Public Health Response to Dementia 2017–2025. It proposes actions to be taken by governments, civil society, and other global and regional partners across seven action areas, one of which is dementia risk reduction. This paper is based on WHO Guidelines on risk reduction of cognitive decline and dementia and presents recommendations on evidence-based, multisectoral interventions for reducing dementia risks, considerations for their implementation and policy actions. These global evidence-informed recommendations were developed by WHO, following a rigorous guideline development methodology and involved a panel of academicians and clinicians with multidisciplinary expertise and representing geographical diversity. The recommendations are considered under three broad headings: lifestyle and behaviour interventions, interventions for physical health conditions and specific interventions. By supporting health and social care professionals, particularly by improving their capacity to provide gender and culturally appropriate interventions to the general population, the risk of developing dementia can be potentially reduced, or its progression delayed.
Keywords
- dementia
- dementia risk reduction guidelines
- dementia risk reduction trials
- WHO guidelines
- cognitive decline